[Acute beta blocker poisoning]. 1985

G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt

It is reported of acute beta-blocker intoxications in 34 patients (16 with talinolol, 18 with propranolol ingestion). The mean ingestion dose was for talinolol 2.5 g, for propranolol 1.55 g, the mean time of latency up to the appearance of intoxication symptoms 116 min after intake of talinolol, 79 min after intake of propranolol. The picture of intoxication was characterized in the two substances by the antiadrenergic effects, there was no more a cardioselectivity in the high ingestion doses. In talinolol were in the first place dysrhythmias, hypotension and vomiting and nausea, respectively, in propranolol central-nervous symptoms and hypotension. Substance-specific intoxication symptoms are also possible. In mixed intoxications alcohol accelerated the beginning of the effect, sedatives prolonged the latency. Threatening of life is to be expected in ingestion doses over 2 g. In 6 patients the course was lethal after extreme doses of talinolol - according to the present experiences due to the too late beginning of therapy and/or insufficient intensity of therapy. Distinct intoxication symptoms need extremely high applications of antidotes of beta-stimulants, in their inffectiveness glucagon. Furthermore, treatment with cardiac pacemakers and 24-hour control in an intensive care unit proved necessary.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
September 1986, Presse medicale (Paris, France : 1983),
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
September 1981, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
April 1980, Lancet (London, England),
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
June 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
October 1999, Deutsche medizinische Wochenschrift (1946),
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
January 2007, Medicina (Kaunas, Lithuania),
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
September 1986, Annals of emergency medicine,
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
May 1980, Lancet (London, England),
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
July 1980, Lancet (London, England),
G Oltmanns, and H Schwela, and B Kulick, and J Knappe, and K O Haustein, and H Schmidt
May 1980, Lancet (London, England),
Copied contents to your clipboard!